Opoka-Winiarska, Violetta
Żuber, Zbigniew
Alexeeva, Ekaterina
Chasnyk, Vyacheslav
Nikishina, Irina
Dębowska, Grażyna
Smolewska, Elżbieta
Article History
Received: 14 January 2018
Revised: 11 March 2018
Accepted: 15 March 2018
First Online: 13 April 2018
Compliance with ethical standards
:
: VO-W declares speaker’s fees from Roche, Abbvie, Pfizer, outside the submitted work. Z.Ż declares no conflicts of interest. EA has received research grants from Roche, Abbott, Pfizer, Bristol-Myers Squibb, Centocor, and Novartis and received honoraria as a speaker for Roche, Novartis, and Pfizer. VCh declares no conflicts of interest. IN has received speaker’s fees from Roche, AbbVie, Pfizer, Bristol-Myers Squibb, and Novartis. GD was an employee of Roche Polska Sp. z o.o. till 30.04.2015 (during the research concept and protocol development, in the time of study conduct, data analysis, and result interpretation). ES declares no conflicts of interest.
: Obtained.
: The study was conducted in accordance with the Declaration of Helsinki and good clinical practice guidelines and with local requirements.